Organisation paid for research Program year 2022 Source: CMS Open Payments

Central Florida Eye Associates

Neither a doctor nor a teaching hospital

Research payments

$910,388

10 payments

Through program year 2022, Central Florida Eye Associates is reported as receiving $910,388 in research payments, across 10 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$844,463	5
2021	Research	$49,800	2
2019	Research	$16,125	3

Breakdown

Who paid Research payments · program years 2019–2022

Padagis US LLC $844,463 5 payments
Perrigo Company plc $62,650 4 payments
Ocular Therapeutix, Inc. $3,275 1 payment

Studies the money was for Research payments · program years 2019–2022

Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide Brimonidine Ophthalmic Suspension 1 percent to Simbrinza in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes $844,463 5 payments
Bioequivalence study $49,800 2 payments
Bioequivalence study between Perrigo's product and Azopt ophthalmic Suspension $12,850 2 payments
A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3a Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension $3,275 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.